MERLN is the Institute for Technology-Inspired Regenerative Medicine at Maastricht University, where we aim to maintain a leading position in the field of biomedical engineering by combining creative research with training of a new generation of interdisciplinary scientists. MERLN’s activities operate at the interface of biology and engineering and we strive to maximize outreach at the level of public involvement, development and commercialization of research. This is also reflected by MERLN’s vision of sharing knowledge, infrastructure, and ambition.

Our research program is focused on developing novel and breakthrough technologies to advance the field of repair and regeneration of both tissues and functional organs. This strategy includes, amongst others, the development of “smart” biomaterials which can trigger intrinsic tissue repair mechanisms mediated by the patient’s own cells.

MERLN has an extensive network of collaborators within research institutions in and outside the Netherlands as well as with a number of biomedical companies, including their own spin-off companies. Being situated in a hospital setting, close collaboration with medical experts expedites the testing and use of our technologies in a clinically relevant setting.

Version: 23/03/2018